Thoracic sympathectomy in the surgical treatment of Raynaud's phenomenon
Delgado Daza, R.; Moga Donadeu, L.; Mañosa Bonamich, J.; Muncunill Gil, J.; Vidal Conde, V.
Angiologia 43(5): 180-182
1991
ISSN/ISBN: 0003-3170 PMID: 1755539 Document Number: 378934
Authors present their results from a review of 38 thoracic sympathectomies practiced since 1977 to 1987, both included, on patients affected by a Raynaud syndrome resistant to medical treatment. Results show the evident clinical improvement of such patients after surgery. In all cases, surgical approach was a Crafoord thoracotomy.
Document emailed within 1 workday
Related Documents
Czyzewski, D.; Dobosz, J.; Wojtacha, J.; Kozielski, J.; Lipka, M.; Lazar-Czyzewska, B. 2004: Assessment of thoracic sympathectomy by transpleural posterolateral and thoracoscopic approach in surgical treatment of Raynaud's syndrome Wiadomosci Lekarskie 57(3-4): 109-113Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763
Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Thulesius, O. 1979: Psychiatric treatment of Raynaud's phenomenon Lakartidningen 76(47): 4234
Bart, P.A.; Waeber, B. 2006: Understanding Raynaud's phenomenon: towards a better treatment Revue Medicale Suisse 2(48): 93-96
Di Biase, A. 2013: Mesoglycan treatment in Raynaud phenomenon: a case series Minerva Cardioangiologica 61(3): 323-331
Kahan, A.; Weber, S.; Amor, B.; Guerin, F.; Degeorges, M. 1983: Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon New England Journal of Medicine 308(18): 1102-1103
Adair, J.R.; Theobald, D.E. 1978: Raynaud's Phenomenon: treatment of a severe case with biofeedback Journal of the Indiana State Medical Association 71(10): 990-993
Buryĭ, V.T.; Buryĭ, V.V. 2008: The treatment of neurospastic vascular diseases in Raynaud phenomenon Klinichna Khirurhiia 6: 36-39
Dowd, P.M.; Martin, M.F.; Cooke, E.D.; Bowcock, S.A.; Jones, R.; Dieppe, P.A.; Kirby, J.D. 1982: Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) British Journal of Dermatology 106(1): 81-89
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654
Belch, J.J.; Shaw, B.; O'Dowd, A.; Saniabadi, A.; Leiberman, P.; Sturrock, R.D.; Forbes, C.D. 1985: Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study Thrombosis and Haemostasis 54(2): 490-494
Lakshminarayanan, S.; Vázquez-Abad, D.; Maestrello, S.J.; Waterman, J.R. 1999: Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator Clinical and Experimental Rheumatology 17(2): 260
Neuhauser, B.; Perkmann, R.; Klingler, P.J.; Giacomuzzi, S.; Kofler, A.; Fraedrich, G. 2001: Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon American Surgeon 67(11): 1096-1097
Ranieri, G.; De Mitrio, V.; Petronelli, M.; Ancona, A.; Dammacco, F. 1988: Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia La Clinica Terapeutica 126(5): 335-343
Kyle, M.V.; Belcher, G.; Hazleman, B.L. 1992: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon Journal of Rheumatology 19(9): 1403-1406
Lowell, R.C.; Gloviczki, P.; Cherry, K.J.; Bower, T.C.; Hallett, J.W.; Schirger, A.; Pairolero, P.C. 1993: Cervicothoracic sympathectomy for Raynaud's syndrome International Angiology: a Journal of the International Union of Angiology 12(2): 168-172
Lasfargues, G.; Royere, D.; Perrotin, D.; Titon, J.P.; Soutif, D.; Guilmot, J.L. 1987: Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon Journal des Maladies Vasculaires 12(4): 319-322
Malone, P.S.; Cameron, A.E.; Rennie, J.A. 1986: Endoscopic thoracic sympathectomy in the treatment of upper limb hyperhidrosis Annals of the Royal College of Surgeons of England 68(2): 93-94
Zapalski, S.; Ciszewski, A.; Napierala, M.; Piskorz, A. 1974: Importance of thoracic sympathectomy in the treatment of ischemia of the upper extremities Polski Przeglad Chirurgiczny 46(9): 1197-1202